SEC 13F Intelligence

Brandywine Global Investment Management, LLC / ALXN

Brandywine Global Investment Management, LLC’s Alexion Pharmaceuticals Inc Position

Does Brandywine Global Investment Management, LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 128.3K shares worth $24M in Q2 2021; the fund’s latest 13F (Q4 2025) no longer reports it.

Position Value
$24M
Q2 2021
Shares
128.3K
% of Portfolio
+0.17%
Quarters Held
6
position exited

Position History ALXN

Reported value by quarter
Q1 ’20: $17MQ1 ’20Q2 ’20: $42MQ2 ’20Q3 ’20: $42MQ3 ’20Q4 ’20: $60MQ4 ’20Q1 ’21: $47MQ1 ’21Q2 ’21: $24MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021128.3K$24M+0.17%
Q1 2021304.7K$47M+0.35%
Q4 2020381.6K$60M+0.50%
Q3 2020371.1K$42M+0.42%
Q2 2020375.1K$42M+0.43%
Q1 2020192.5K$17M+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Brandywine Global Investment Management, LLC’s full portfolio or all institutional holders of ALXN.